A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021

A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021

ABSTRACT Background Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death in China. The rapid progress in systemic therapies has led to the approval of many therapeutic methods that have quickly changed clinical guidelines and practices. Because of the high heterogeneity...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong Zhao, Yilei Mao, Hongguang Wang, Aiping Zhou, Zhengqiang Yang, Yue Han, Gong Li, Xinyu Bi, Chunyi Hao, Xiaodong Wang, Jun Zhou, Chaoliu Dai, Feng Wen, Jingdong Zhang, Ruibao Liu, Tao Li, Lei Zhao, Zuoxing Niu, Tianfu Wen, Qiu Li, Hongmei Zhang, Xiaoming Chen, Minshan Chen, Ming Zhao, Yajin Chen, Jun Yu, Jie Shen, Xiangchen Li, Lianxin Liu, Zhiyong Huang, Wei Zhang, Feng Shen, Weiping Zhou, Zhengang Yuan, Jian Zhai, Ningling Ge, Yongjun Chen, Huichuan Sun, Jianqiang Cai
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Cancer Innovation
Subjects:
adjuvant therapy
downstaging/conversion therapy
immunotherapy
neoadjuvant therapy
TKI
Online Access:https://doi.org/10.1002/cai2.70006
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items